sevoflurane has been researched along with Acute Respiratory Distress Syndrome in 16 studies
Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Compared with isoflurane, sevoflurane did not affect lung inflammation in ARDSexp, but it did reduce lung inflammation in ARDSp." | 7.85 | Sevoflurane, Compared With Isoflurane, Minimizes Lung Damage in Pulmonary but Not in Extrapulmonary Acute Respiratory Distress Syndrome in Rats. ( Araújo, MN; Cavalcanti, VCM; Cruz, FF; Felix, NS; Fernandes, FC; Heil, LBB; Morales, MM; Pelosi, P; Rocco, PRM; Samary, CS; Santos, CL; Silva, JD; Silva, PL; Villela, NR, 2017) |
| "The goal of this study was to confirm whether or not sevoflurane is more effective than propofol in ameliorating the inflammatory response in an animal model of acute respiratory distress syndrome." | 7.79 | Sevoflurane, but not propofol, reduces the lung inflammatory response and improves oxygenation in an acute respiratory distress syndrome model: a randomised laboratory study. ( Aguilar, G; Belda, FJ; Ferrando, C; Moreno, J; Piqueras, L; Soro, M, 2013) |
| "Sevoflurane has a stimulating effect on ENaC and Na(+) /K(+) -ATPase in vitro in LPS-injured AECII." | 5.38 | Sevoflurane reduces severity of acute lung injury possibly by impairing formation of alveolar oedema. ( Beck-Schimmer, B; Booy, C; Lachmann, RA; Leutert, AC; Schläpfer, M; Voigtsberger, S, 2012) |
| "Compared with isoflurane, sevoflurane did not affect lung inflammation in ARDSexp, but it did reduce lung inflammation in ARDSp." | 3.85 | Sevoflurane, Compared With Isoflurane, Minimizes Lung Damage in Pulmonary but Not in Extrapulmonary Acute Respiratory Distress Syndrome in Rats. ( Araújo, MN; Cavalcanti, VCM; Cruz, FF; Felix, NS; Fernandes, FC; Heil, LBB; Morales, MM; Pelosi, P; Rocco, PRM; Samary, CS; Santos, CL; Silva, JD; Silva, PL; Villela, NR, 2017) |
| "The goal of this study was to confirm whether or not sevoflurane is more effective than propofol in ameliorating the inflammatory response in an animal model of acute respiratory distress syndrome." | 3.79 | Sevoflurane, but not propofol, reduces the lung inflammatory response and improves oxygenation in an acute respiratory distress syndrome model: a randomised laboratory study. ( Aguilar, G; Belda, FJ; Ferrando, C; Moreno, J; Piqueras, L; Soro, M, 2013) |
| "An 82-year-old woman with amyotrophic lateral sclerosis (ALS) with bulbar paralysis, respiratory muscle paralysis, and arteriosclerosis obliterans (ASO) of the lower extremities, underwent uneventful general anesthesia with remifentanil and sevoflurane for bilateral below-knee amputation." | 3.74 | [Anesthetic management of an ALS patient with remifentanil]. ( Tagami, N; Umegaki, H, 2008) |
| "We conclude that the severity of remote lung injury was not different between sevoflurane and propofol anaesthesia in this porcine model of severe lower-body ischaemia and reperfusion injury." | 3.74 | Lung injury following thoracic aortic occlusion: comparison of sevoflurane and propofol anaesthesia. ( Annecke, T; Bittmann, I; Conzen, PF; Hilberath, JM; Kahr, S; Kemming, GI; Krombach, F; Kubitz, JC; Langer, K; Rehm, M, 2008) |
| "Sevoflurane has a stimulating effect on ENaC and Na(+) /K(+) -ATPase in vitro in LPS-injured AECII." | 1.38 | Sevoflurane reduces severity of acute lung injury possibly by impairing formation of alveolar oedema. ( Beck-Schimmer, B; Booy, C; Lachmann, RA; Leutert, AC; Schläpfer, M; Voigtsberger, S, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 6 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Reins, J | 1 |
| Balling, F | 1 |
| Baader, C | 1 |
| Böck, E | 1 |
| Schöniger, W | 1 |
| van Erp, R | 1 |
| Eff, S | 1 |
| Hafner, S | 1 |
| Orser, BA | 1 |
| Wang, DS | 1 |
| Lu, WY | 1 |
| Nieuwenhuijs-Moeke, GJ | 1 |
| Jainandunsing, JS | 1 |
| Struys, MMRF | 1 |
| Jerath, A | 1 |
| Ferguson, ND | 1 |
| Cuthbertson, B | 1 |
| Liang, Z | 1 |
| Zhou, H | 1 |
| Tang, R | 1 |
| Zhang, S | 1 |
| Chen, X | 1 |
| Pei, L | 1 |
| Qiu, Y | 1 |
| Zhang, R | 1 |
| Riché, A | 1 |
| Adam, N | 1 |
| Monsel, A | 1 |
| Xia, J | 1 |
| Langeron, O | 1 |
| Rouby, JJ | 1 |
| Blondonnet, R | 1 |
| Godet, T | 1 |
| Futier, E | 1 |
| Bazin, JE | 1 |
| Constantin, JM | 1 |
| Jabaudon, M | 1 |
| Ferrando, C | 1 |
| Aguilar, G | 1 |
| Piqueras, L | 1 |
| Soro, M | 1 |
| Moreno, J | 1 |
| Belda, FJ | 1 |
| Araújo, MN | 1 |
| Santos, CL | 1 |
| Samary, CS | 1 |
| Heil, LBB | 1 |
| Cavalcanti, VCM | 1 |
| Cruz, FF | 1 |
| Felix, NS | 1 |
| Silva, JD | 1 |
| Morales, MM | 1 |
| Pelosi, P | 1 |
| Fernandes, FC | 1 |
| Villela, NR | 1 |
| Silva, PL | 1 |
| Rocco, PRM | 1 |
| Umegaki, H | 1 |
| Tagami, N | 1 |
| Schläpfer, M | 1 |
| Leutert, AC | 1 |
| Voigtsberger, S | 1 |
| Lachmann, RA | 1 |
| Booy, C | 1 |
| Beck-Schimmer, B | 1 |
| Fuzaylov, G | 1 |
| Cauley, BD | 1 |
| Fatheree, RS | 1 |
| Leighton, BL | 1 |
| Sun, YH | 1 |
| Zhang, Q | 1 |
| Wang, JK | 1 |
| Cui, Y | 1 |
| Annecke, T | 1 |
| Kubitz, JC | 1 |
| Langer, K | 1 |
| Hilberath, JM | 1 |
| Kahr, S | 1 |
| Krombach, F | 1 |
| Bittmann, I | 1 |
| Rehm, M | 1 |
| Kemming, GI | 1 |
| Conzen, PF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| AnaConDa-therapy in COVID-19 Patients[NCT05586126] | 42 participants (Actual) | Observational | 2020-10-01 | Terminated (stopped due to Concerns about possible association between drug and increased ICU mortality) | |||
| A Phase 3, Multicenter, Randomized, Controlled, Open Label, Assessor-Blinded Study to Evaluate the Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensi[NCT05327296] | Phase 3 | 235 participants (Anticipated) | Interventional | 2022-06-30 | Recruiting | ||
| A Phase 3, Multicenter, Randomized, Controlled, Open Label, Assessor-Blinded Study to Evaluate the Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensi[NCT05312385] | Phase 3 | 235 participants (Anticipated) | Interventional | 2022-04-28 | Recruiting | ||
| Volatile Anesthetic Pharmacokinetics During Extracorporeal Membrane[NCT05680545] | 10 participants (Anticipated) | Interventional | 2024-07-01 | Not yet recruiting | |||
| A Randomized Pilot Clinical Trial of the Effects in Oxygenation and Hypoxic Pulmonary Vasoconstriction of Sevoflurane in Patient's Whit ARDS Secondary to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2)[NCT04998253] | Early Phase 1 | 24 participants (Actual) | Interventional | 2020-10-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for sevoflurane and Acute Respiratory Distress Syndrome
| Article | Year |
|---|---|
Inhalational volatile-based sedation for COVID-19 pneumonia and ARDS.
Topics: Algorithms; Anesthetics, Inhalation; Anesthetics, Intravenous; Betacoronavirus; Coronavirus Infectio | 2020 |
Inhalational volatile-based sedation for COVID-19 pneumonia and ARDS.
Topics: Algorithms; Anesthetics, Inhalation; Anesthetics, Intravenous; Betacoronavirus; Coronavirus Infectio | 2020 |
Inhalational volatile-based sedation for COVID-19 pneumonia and ARDS.
Topics: Algorithms; Anesthetics, Inhalation; Anesthetics, Intravenous; Betacoronavirus; Coronavirus Infectio | 2020 |
Inhalational volatile-based sedation for COVID-19 pneumonia and ARDS.
Topics: Algorithms; Anesthetics, Inhalation; Anesthetics, Intravenous; Betacoronavirus; Coronavirus Infectio | 2020 |
Inhalational volatile-based sedation for COVID-19 pneumonia and ARDS.
Topics: Algorithms; Anesthetics, Inhalation; Anesthetics, Intravenous; Betacoronavirus; Coronavirus Infectio | 2020 |
Inhalational volatile-based sedation for COVID-19 pneumonia and ARDS.
Topics: Algorithms; Anesthetics, Inhalation; Anesthetics, Intravenous; Betacoronavirus; Coronavirus Infectio | 2020 |
Inhalational volatile-based sedation for COVID-19 pneumonia and ARDS.
Topics: Algorithms; Anesthetics, Inhalation; Anesthetics, Intravenous; Betacoronavirus; Coronavirus Infectio | 2020 |
Inhalational volatile-based sedation for COVID-19 pneumonia and ARDS.
Topics: Algorithms; Anesthetics, Inhalation; Anesthetics, Intravenous; Betacoronavirus; Coronavirus Infectio | 2020 |
Inhalational volatile-based sedation for COVID-19 pneumonia and ARDS.
Topics: Algorithms; Anesthetics, Inhalation; Anesthetics, Intravenous; Betacoronavirus; Coronavirus Infectio | 2020 |
15 other studies available for sevoflurane and Acute Respiratory Distress Syndrome
| Article | Year |
|---|---|
[Nephrogenic diabetes insipidus after inhalation sedation with sevoflurane in a patient with COVID-19-associated acute respiratory distress syndrome].
Topics: Anesthetics, Inhalation; COVID-19; Diabetes Insipidus, Nephrogenic; Diabetes Mellitus; Humans; Pneum | 2023 |
Sedating ventilated COVID-19 patients with inhalational anesthetic drugs.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pilot Projects; Pneumonia, Vir | 2020 |
Sevoflurane, a sigh of relief in COVID-19?
Topics: Anesthetics, Inhalation; Conscious Sedation; Coronavirus Infections; COVID-19; Humans; Pandemics; Pn | 2020 |
Autologous transplantation of adipose-derived stromal cells combined with sevoflurane ameliorates acute lung injury induced by cecal ligation and puncture in rats.
Topics: Acute Lung Injury; Adipose Tissue; Animals; Bronchoalveolar Lavage Fluid; Cecum; Cell- and Tissue-Ba | 2020 |
Perioperative respiratory distress in a child due to plastic bronchitis triggered by allergic reaction to sevoflurane.
Topics: Airway Obstruction; Anesthetics, Inhalation; Bronchitis; Bronchodilator Agents; Child, Preschool; Dr | 2020 |
Sevoflurane in Acute Respiratory Distress Syndrome: Are Lung Protection and Anesthesia Depth Influenced by Pulmonary Morphology?
Topics: Anesthesia; Humans; Lung; Pilot Projects; Respiratory Distress Syndrome; Sevoflurane | 2018 |
Reply to Riché et al.: Sevoflurane in Acute Respiratory Distress Syndrome: Are Lung Protection and Anesthesia Depth Influenced by Pulmonary Morphology?
Topics: Anesthesia; Humans; Lung; Pilot Projects; Respiratory Distress Syndrome; Sevoflurane | 2018 |
Sevoflurane, but not propofol, reduces the lung inflammatory response and improves oxygenation in an acute respiratory distress syndrome model: a randomised laboratory study.
Topics: Anesthesia; Anesthetics, Inhalation; Animals; Cell Membrane Permeability; Disease Models, Animal; He | 2013 |
Sevoflurane, but not propofol, reduces the lung inflammatory response and improves oxygenation in an acute respiratory distress syndrome model: a randomised laboratory study.
Topics: Anesthesia; Anesthetics, Inhalation; Animals; Cell Membrane Permeability; Disease Models, Animal; He | 2013 |
Sevoflurane, but not propofol, reduces the lung inflammatory response and improves oxygenation in an acute respiratory distress syndrome model: a randomised laboratory study.
Topics: Anesthesia; Anesthetics, Inhalation; Animals; Cell Membrane Permeability; Disease Models, Animal; He | 2013 |
Sevoflurane, but not propofol, reduces the lung inflammatory response and improves oxygenation in an acute respiratory distress syndrome model: a randomised laboratory study.
Topics: Anesthesia; Anesthetics, Inhalation; Animals; Cell Membrane Permeability; Disease Models, Animal; He | 2013 |
Sevoflurane, but not propofol, reduces the lung inflammatory response and improves oxygenation in an acute respiratory distress syndrome model: a randomised laboratory study.
Topics: Anesthesia; Anesthetics, Inhalation; Animals; Cell Membrane Permeability; Disease Models, Animal; He | 2013 |
Sevoflurane, but not propofol, reduces the lung inflammatory response and improves oxygenation in an acute respiratory distress syndrome model: a randomised laboratory study.
Topics: Anesthesia; Anesthetics, Inhalation; Animals; Cell Membrane Permeability; Disease Models, Animal; He | 2013 |
Sevoflurane, but not propofol, reduces the lung inflammatory response and improves oxygenation in an acute respiratory distress syndrome model: a randomised laboratory study.
Topics: Anesthesia; Anesthetics, Inhalation; Animals; Cell Membrane Permeability; Disease Models, Animal; He | 2013 |
Sevoflurane, but not propofol, reduces the lung inflammatory response and improves oxygenation in an acute respiratory distress syndrome model: a randomised laboratory study.
Topics: Anesthesia; Anesthetics, Inhalation; Animals; Cell Membrane Permeability; Disease Models, Animal; He | 2013 |
Sevoflurane, but not propofol, reduces the lung inflammatory response and improves oxygenation in an acute respiratory distress syndrome model: a randomised laboratory study.
Topics: Anesthesia; Anesthetics, Inhalation; Animals; Cell Membrane Permeability; Disease Models, Animal; He | 2013 |
Sevoflurane, Compared With Isoflurane, Minimizes Lung Damage in Pulmonary but Not in Extrapulmonary Acute Respiratory Distress Syndrome in Rats.
Topics: A549 Cells; Anesthetics; Animals; Escherichia coli; Female; Humans; Inflammation; Interleukin-6; Iso | 2017 |
[Anesthetic management of an ALS patient with remifentanil].
Topics: Aged, 80 and over; Amputation, Surgical; Amyotrophic Lateral Sclerosis; Anesthesia, General; Arterio | 2008 |
Sevoflurane reduces severity of acute lung injury possibly by impairing formation of alveolar oedema.
Topics: Acute Lung Injury; Anesthetics; Animals; Biological Transport, Active; Cell Line; Cell Survival; Lip | 2012 |
Spontaneous ventilation via facemask and laryngeal mask airway as bridge to extracorporeal membrane oxygenation during long-segment tracheal stenosis repair.
Topics: Airway Management; Anesthesia, General; Anesthetics, Inhalation; Bronchoscopy; Carbon Dioxide; Extra | 2012 |
Acute respiratory distress syndrome after an exothermic Baralyme-sevoflurane reaction.
Topics: Absorption; Adult; Anesthetics, Inhalation; Barium Compounds; Calcium Hydroxide; Carbon Dioxide; Car | 2004 |
[Effects of sevoflurane on membrane permeability of alveolar capillaries in rats with acute lung injury caused by endotoxin].
Topics: Animals; Blood-Air Barrier; Bronchoalveolar Lavage Fluid; Capillary Permeability; Endotoxins; Female | 2004 |
Lung injury following thoracic aortic occlusion: comparison of sevoflurane and propofol anaesthesia.
Topics: Anesthesia; Anesthetics, Inhalation; Anesthetics, Intravenous; Animals; Aorta, Thoracic; Arterial Oc | 2008 |